Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
AstraZeneca to transfer global rights for Eklira and Duaklir to Covis Pharma
-
Imfinzi plus chemotherapy significantly improved overall survival in 1st-line advanced biliary tract cancer in TOPAZ-1 Phase III trial at interim analysis
-
Imfinzi plus tremelimumab significantly improved overall survival in HIMALAYA Phase III trial in 1st-line unresectable liver cancer
-
AZD7442 reduced risk of developing severe COVID-19 or death in TACKLE Phase III outpatient treatment trial
-
Tezepelumab granted Orphan Drug Designation in the US for eosinophilic esophagitis
-
AZD7442 request for Emergency Use Authorization for COVID-19 prophylaxis filed in US
-
Enhertu granted Breakthrough Therapy Designation in US for patients with HER2-positive metastatic breast cancer treated with one or more prior anti-HER2-based regimens
-
AstraZeneca to fully acquire Caelum Biosciences
-
Saphnelo approved in Japan for systemic lupus erythematosus
-
AstraZeneca COVID-19 and RSV presentations at IDWeek 2021 will showcase scientific progress in infectious diseases
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here
